These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Onset of polycythemia in idiopathic myelofibrosis. Description of a clinical case and review of the literature]. Pagano L; Teofili L; Marra R; Storti S; Rabbitti C; Leone G; Bizzi B Minerva Med; 1988 Jan; 79(1):51-4. PubMed ID: 3277085 [TBL] [Abstract][Full Text] [Related]
3. The natural history of agnogenic myeloid metaplasia (AMM) and a critical evaluation of its relationship with the myeloproliferative syndrome. Ward HP; Block MH Medicine (Baltimore); 1971 Sep; 50(5):357-420. PubMed ID: 4940717 [No Abstract] [Full Text] [Related]
7. [Effectiveness of splenectomy in myeloproliferative disorders complicated by portal hypertension]. Demidova AV; Zelenkina LV Ter Arkh; 1980; 52(12):82-5. PubMed ID: 7245077 [No Abstract] [Full Text] [Related]
8. Blood and neoplastic diseases. Myeloproliferative disorders. Lewis SM; Szur L Br Med J; 1974 Nov; 4(5941):399-402. PubMed ID: 4425895 [No Abstract] [Full Text] [Related]
9. [Current therapeutic possibilities in idiopathic myelofibrosis. Observations on 47 cases]. Perugini S; Ascari E; Fontana G Clin Ter; 1968 Apr; 45(1):21-60. PubMed ID: 4897957 [No Abstract] [Full Text] [Related]
10. Ectopic medullary hematopoiesis as a cause of ascites in agnogenic myeloid metaplasia. Case report and review of the literature. Knobel B; Melamud E; Virag I; Meytes D Acta Haematol; 1993; 89(2):104-7. PubMed ID: 8503241 [TBL] [Abstract][Full Text] [Related]
11. Suppression of hepatic hematopoiesis with radioactive gold (198Au). Turner AR; Gummerman LW; Boggs DR J Nucl Med; 1985 Apr; 26(4):366-7. PubMed ID: 2984361 [TBL] [Abstract][Full Text] [Related]
12. The syndrome of idiopathic myelofibrosis. A clinicopathologic review with emphasis on the prognostic variables predicting survival. Varki A; Lottenberg R; Griffith R; Reinhard E Medicine (Baltimore); 1983 Nov; 62(6):353-71. PubMed ID: 6633248 [TBL] [Abstract][Full Text] [Related]
13. Some clinical aspects of myelofibrosis: a study of 21 patients. Corneo G; Galli C; Cortellaro M; De Pangher V; Polli E Haematologica; 1977 Oct; 62(5):517-28. PubMed ID: 412738 [No Abstract] [Full Text] [Related]
14. Myelofibrosis with myeloid metaplasia. Tefferi A N Engl J Med; 2000 Apr; 342(17):1255-65. PubMed ID: 10781623 [No Abstract] [Full Text] [Related]
15. The reversal of myelofibrosis associated with chronic myelogenous leukemia after allogeneic bone marrow transplantation. Oblon DJ; Elfenbein GJ; Braylan RC; Jones J; Weiner RS Exp Hematol; 1983 Aug; 11(7):681-5. PubMed ID: 6350032 [TBL] [Abstract][Full Text] [Related]
16. [Subleukemic myelosis - myelofibrosis]. Demidova AV Ter Arkh; 1982; 54(9):135-43. PubMed ID: 7179142 [No Abstract] [Full Text] [Related]
17. [Successful treatment of primary myelofibrosis by busulfan pulse therapy: report of a case]. Uemura Y; Iwahara Y; Kataoka R; Muneishi H; Miyoshi I Rinsho Ketsueki; 1990 Sep; 31(9):1553-6. PubMed ID: 2246832 [TBL] [Abstract][Full Text] [Related]
18. The spleen in myeloproliferative disorders. Goldman JM; Nolasco I Clin Haematol; 1983 Jun; 12(2):505-16. PubMed ID: 6352114 [No Abstract] [Full Text] [Related]
19. A sequential histological study of bone marrow fibrosis in idiopathic myelofibrosis. Hasselbalch H; Lisse I Eur J Haematol; 1991 May; 46(5):285-9. PubMed ID: 2044723 [TBL] [Abstract][Full Text] [Related]
20. Splenectomy in myelofibrosis with myeloid metaplasia: a single-institution experience with 223 patients. Tefferi A; Mesa RA; Nagorney DM; Schroeder G; Silverstein MN Blood; 2000 Apr; 95(7):2226-33. PubMed ID: 10733489 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]